The Journal of Clinical Psychiatry

Page 520

More JCP Articles

Article

New Nomenclature for Drug-Induced Movement Disorders Including Tardive Dyskinesia

May 1, 2004

Guy Chouinard

Original Research

A Novel, Point-of-Care Test for Lithium Levels: Description and Reliability

May 1, 2004

William M. Glazer, John G. Sonnenberg, Michael J. Reinstein, et al

Article

Panel Discussion: Changing How We Think About Insomnia

May 1, 2004

Andrew D. Krystal, Thomas Roth, Jack D. Edinger, et al

Article

Pathophysiology of Antipsychotic Drug-Induced Movement Disorders

May 1, 2004

Daniel E. Casey

Original Research

Patterns of Concomitant Psychotropic Medication Use During a 2-Year Study Comparing Clozapine and Olanzapine for the Prevention of Suicidal Behavior

May 1, 2004

Ira D. Glick, Rocco Zaninelli, Chuanchieh Hsu, et al

Original Research

Prevalence of Diabetes Mellitus Among Outpatients With Severe Mental Disorders Receiving Atypical Antipsychotic Drugs

May 1, 2004

J. Steven Lamberti, G. Oana Costea, David Olson, et al

Letter to the Editor

Response to Commentary: “Using Questionnaires to Screen for Psychiatric Disorders.”

May 1, 2004

Joseph R. Calabrese, Mark A. Frye, Robert M. A. Hirschfeld, et al

Original Research

Risperidone in Combination With Mood Stabilizers: A 10-Week Continuation Phase Study in Bipolar I Disorder

May 1, 2004

Charles L. Bowden, Fred Grossman, Joyce E. Myers, et al

Original Research

Risperidone in the Treatment of Delirium: Results From a Prospective Open-Label Trial

May 1, 2004

Henry A. Nasrallah, Dinesh Mittal, Nita A. Jimerson, et al

Book Review

Schizophernia Into Later Life: Treatment, Research, and Policy

May 1, 2004

Myung A. Lee

Letter to the Editor

Schizophrenia as a Manifestation of X-Linked McLeod-Neuroacanthocytosis Syndrome

May 1, 2004

Hans H. Jung, Helene Haker

Article

Schizophrenia, Metabolic Disorders, and Cardiovascular Disease

May 1, 2004

John W. Newcomer, Daniel E. Casey, Dan W. Haupt, et al

« 1 … 518 519 520 521 522 … 764 »